Elementis (ELMTY) Lowered to “Hold” at Zacks Investment Research

Original Source    2018-05-02 09:05

Elementis (OTCMKTS:ELMTY) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “Elementis plc is a specialty chemicals company. Its business comprises of Specialty Products, Chromium and Surfactants. The company’s product consists of BENTONE(R) organoclays, RHEOLATE(R) rheological additives, DAPRO(R) specialty additives, M-P-A(R) anti-settling agents, NALZIN(R) corrosion and rust inhibitors, THIXATROL(R) rheology additives, NUOSPERSE(R) wetting and dispersing agents, TINT-AYD (R)colorants, SLIP-AYD(R) waxes and slip additives, SERDOX(R) polyglycol ethers, SERDOLAMIDE(R) alkanolamides and SERVOXYL(R) phosphate esters. Elementis plc is based in London, United Kingdom. “

ELMTY traded down $1.36 during trading on Tuesday, reaching $16.44. The stock had a trading volume of 100 shares, compared to its average volume of 317. The company has a current ratio of 2.66, a quick ratio of 1.67 and a debt-to-equity ratio of 0.49. The company has a market cap of $1,906.38, a price-to-earnings ratio of 24.53, a price-to-earnings-growth ratio of 3.91 and a beta of 0.94. Elementis has a one year low of $15.59 and a one year high of $20.32.

About Elementis

Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.

Get a free copy of the Zacks research report on Elementis (ELMTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Elementis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Elementis and related companies with MarketBeat.com’s FREE daily email newsletter.

Original Source